Ami Organics Limited – FDA 483, Mar 13, 2020

An FDA inspection of Ami Organics Pvt. Ltd. in Surat, India, an API intermediates manufacturer, revealed significant deficiencies in data integrity and record management. Observations included failures to retain manufacturing records, validate analytical methods, control computerized systems, and ensure accurate laboratory calculations. These issues indicate a lack of robust quality control and data governance practices.